FRASER CRAIG (President and CEO) received a stock award from WINDTREE THERAPEUTICS INC /DE/
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/25/2023ACC: 0001437749-23-024710
DirectorOfficer· President and CEO
Since Nov 2018
+114.67K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
114.67K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+45.87K
Price / share
—
Trade value
—
% of position
654.3%
8/23/2023
7.01K→52.88K
Total
Net shares
+45.87K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/23/2023 | A · Award | +45.87K | — | — | 654.3% | 7.01K | 52.88K |
| Total | +45.87K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
68.80K shares
Shares
+68.80K
Strike price
1.21
Held after
68.80K
Exercisable
—
8/23/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock68.80K shares | 8/23/2023 | A · Award | +68.80K | 1.21 | — | 68.80K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned3.00
Total
3.00 indirect3.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.00 | Indirect |
| Total | 3.00 | 3.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported